Bittoo Kanwar

Bittoo Kanwar

Keine laufenden Positionen mehr

Vermögen: 15 211 $ am 30.11.2023

48 Jahre
Health Technology
Consumer Services

Ursprung des Netzwerks ersten Grades von Bittoo Kanwar

EinheitArt der EinheitIndustrie
Public Company Biotechnology 14

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Bittoo Kanwar

UnternehmenSektorVerknüpfte PersonenHauptposition
UNITY BIOTECHNOLOGY, INC. Biotechnology

Graham Cooper

Douglas A. Rich

John Smither

Director/Board Member

Chief Operating Officer

Director of Finance/CFO

Pharmaceuticals: Major

Helen Kim

Randall J. Mrsny

Director/Board Member

Founder

Pharmaceuticals: Major

Helen Kim

Charles Olson

Corporate Officer/Principal

Corporate Officer/Principal

NGM BIOPHARMACEUTICALS, INC. Biotechnology

Helen Kim

Charles Olson

Consultant / Advisor

Corporate Officer/Principal

ASSEMBLY BIOSCIENCES, INC. Pharmaceuticals: Major

Graham Cooper

Helen Kim

Director of Finance/CFO

Director/Board Member

EFFECTOR THERAPEUTICS, INC. Biotechnology

John Smither

Elizabeth Bhatt

Director/Board Member

Director/Board Member

University of California, Davis College/University

Randall J. Mrsny

Charlene Banard

Doctorate Degree

Undergraduate Degree

KYTHERA BIOPHARMACEUTICALS INC Pharmaceuticals: Major

Douglas A. Rich

John Smither

Chief Operating Officer

Director of Finance/CFO

Investment Banks/Brokers

Graham Cooper

Shawn Cross

Corporate Officer/Principal

Analyst-Equity

KITE PHARMA INC Biotechnology

Helen Kim

John Smither

Private Equity Investor

Director of Finance/CFO

Investment Banks/Brokers

Shawn Cross

Corporate Officer/Principal

University of California, Los Angeles College/University

Shawn Cross

Undergraduate Degree

College/University

Shawn Cross

Corporate Officer/Principal

Columbia Business School College/University

Shawn Cross

Masters Business Admin

Investment Banks/Brokers

Shawn Cross

Analyst-Equity

BIOPLUS ACQUISITION CORP. Financial Conglomerates

Shawn Cross

Director/Board Member

Investment Banks/Brokers

Shawn Cross

Corporate Officer/Principal

GT BIOPHARMA, INC. Pharmaceuticals: Major

Shawn Cross

Chief Executive Officer

FRAZIER LIFESCIENCES ACQUISITION CORPORATION Pharmaceuticals: Major

John Smither

Director/Board Member

GENELUX CORPORATION Pharmaceuticals: Major

John Smither

Director/Board Member

Pharmaceuticals: Major

John Smither

Director/Board Member

ARCUTIS BIOTHERAPEUTICS, INC. Pharmaceuticals: Major

John Smither

Director of Finance/CFO

PRINCIPIA BIOPHARMA INC. Pharmaceuticals: Major

John Smither

Director/Board Member

Miscellaneous Commercial Services

John Smither

Director/Board Member

AMGEN INC. Pharmaceuticals: Major

John Smither

Chief Administrative Officer

SIENNA BIOPHARMACEUTICALS, INC. Pharmaceuticals: Major

John Smither

Director of Finance/CFO

Miscellaneous Commercial Services

John Smither

Corporate Officer/Principal

Miscellaneous Commercial Services

John Smither

Corporate Officer/Principal

Medical Distributors

John Smither

Director of Finance/CFO

California Society of Certified Public Accountants

John Smither

Corporate Officer/Principal

CYCLO THERAPEUTICS, INC. Biotechnology

Shawn Cross

Director/Board Member

IMUNON, INC. Biotechnology

Carolyn Finkle

General Counsel

Pharmaceuticals: Major

Charles Olson

President

University of California San Diego College/University

Elizabeth Bhatt

Graduate Degree

St. Mary's College of California College/University

Charlene Banard

Masters Business Admin

NOVARTIS AG Pharmaceuticals: Major

Charlene Banard

Corporate Officer/Principal

Stony Brook School College/University

Holly Schachner

Doctorate Degree

ALLERGAN PLC Pharmaceuticals: Major

Holly Schachner

Corporate Officer/Principal

MYOKARDIA, INC. Pharmaceuticals: Major

Holly Schachner

Corporate Officer/Principal

University of Michigan College/University

Holly Schachner

Undergraduate Degree

Biotechnology

Holly Schachner

Chief Tech/Sci/R&D Officer

Yale School of Medicine College/University

Andy Whitney

Doctorate Degree

AUDENTES THERAPEUTICS, INC. Biotechnology

Andrew H. Chang

Investor Relations Contact

Pharmaceuticals: Major

Elizabeth Bhatt

Chief Operating Officer

GILEAD SCIENCES, INC. Biotechnology

Elizabeth Bhatt

Corporate Officer/Principal

Statistik

International

Vereinigte Staaten 44
Niederlande 3
Vereinigtes Königreich 2
Italien 2
Schweiz 2

Sektoral

Health Technology 29
Consumer Services 10
Finance 9
Commercial Services 4
Distribution Services 2

Operativ

Director/Board Member 44
Corporate Officer/Principal 36
Independent Dir/Board Member 17
Director of Finance/CFO 13
Undergraduate Degree 12
  1. Börse
  2. Insiders
  3. Bittoo Kanwar
  4. Unternehmensverbindungen